New strategies for the next generation of matrix-metalloproteinase inhibitors: Selectively targeting membrane-anchored MMPs with therapeutic antibodies

Biochemistry Research International

Volumn , Issue , 2011, Pages

  Dransfield, Daniel T ^b   Devy, Laetitia ^a  

^a MERCK SERONO S A   (Switzerland)

^b Dyax Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650780565     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2011/191670     Document Type: Review

References (139)

1. Zucker S., Cao J., Chen W.-T., Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment Oncogene 2000 19 56 6642 6650
2. Pei D., Kang T., Qi H., Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation Journal of Biological Chemistry 2000 275 43 33988 33997
3. Velasco G., Pends A. M., Fueyo A., Knuper V., Murphy G., Lpez-Otn C., Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members Journal of Biological Chemistry 1999 274 8 4570 4576
4. Levitt N. C., Eskens F. A. L. M., O'Byrne K. J., Propper D. J., Denis L. J., Owen S. J., Choi L., Foekens J. A., Wilner S., Wood J. M., Nakajima M., Talbot D. C., Steward W. P., Harris A. L., Verweij J., Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer Clinical Cancer Research 2001 7 7 1912 1922 (Pubitemid 32994825)
5. Noe M. C., Natarajan V., Snow S. L., Mitchell P. G., Lopresti-Morrow L., Reeves L. M., Yocum S. A., Carty T. J., Barberia J. A., Sweeney F. J., Liras J. L., Vaughn M., Hardink J. R., Hawkins J. M., Tokar C., Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13 Bioorganic and Medicinal Chemistry Letters 2005 15 11 2808 2811 (Pubitemid 40732225)
6. Lombart H.-G., Feyfant E., Joseph-McCarthy D., Huang A., Lovering F., Sun L., Zhu Y., Zeng C., Zhang Y., Levin J., Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors Bioorganic and Medicinal Chemistry Letters 2007 17 15 4333 4337
7. Pirard B., Insight into the structural determinants for selective inhibition of matrix metalloproteinases Drug Discovery Today 2007 12 15-16 640 646
8. Nordstrm D., Lindy O., Lauhio A., Sorsa T., Santavirta S., Konttinen Y. T., Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis Rheumatology International 1998 17 5 175 180
9. O'Dell J. R., Is there a role for antibiotics in the treatment of patients with rheumatoid arthritis? Drugs 1999 57 3 279 282
10. Stechmiller J., Cowan L., Schultz G., The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds Biological Research for Nursing 2010 11 4 336 344
11. Chirivi R. G. S., Garofalo A., Crimmin M. J., Bawden L. J., Stoppacciaro A., Brown P. D., Giavazzi R., Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor International Journal of Cancer 1994 58 3 460 464
12. Hidalgo M., Eckhardt S. G., Development of matrix metalloproteinase inhibitors in cancer therapy Journal of the National Cancer Institute 2001 93 3 178 193
13. Bloomston M., Zervos E. E., Rosemurgy A. S. II, Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials Annals of Surgical Oncology 2002 9 7 668 674
14. Coussens L. M., Fingleton B., Matrisian L. M., Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 2002 295 5564 2387 2392
15. Sato H., Tumor metastasis and MMP inhibitor Clinical Calcium 2006 16 4 621 626
16. Drummond A. H., Beckett P., Brown P. D., Bone E. A., Davidson A. H., Galloway W. A., Gearing A. J. H., Huxley P., Laber D., McCourt M., Whittaker M., Wood L. M., Wright A., Preclinical and clinical studies of MMP inhibitors in cancer Annals of the New York Academy of Sciences 1999 878 228 235
17. Skiles J. W., Gonnella N. C., Jeng A. Y., The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors Current Medicinal Chemistry 2004 11 22 2911 2977
18. Fingleton B., MMPs as therapeutic targets-still a viable option? Seminars in Cell and Developmental Biology 2008 19 1 61 68
19. Egeblad M., Werb Z., New functions for the matrix metalloproteinases in cancer progression Nature Reviews Cancer 2002 2 3 161 174
20. Della Porta P., Soeltl R., Krell H.-W., Collins K., O'Donoghue M., Schmitt M., Krger A., Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo Anticancer Research 1999 19 5B 3809 3816
21. Krger A., Soeltl R., Sopov I., Kopitz C., Arlt M., Magdolen V., Harbeck N., Gnsbacher B., Schmitt M., Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis Cancer Research 2001 61 4 1272 1275
22. Bergers G., Brekken R., McMahon G., Vu T. H., Itoh T., Tamaki K., Tanzawa K., Thorpe P., Itohara S., Werb Z., Hanahan D., Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nature Cell Biology 2000 2 10 737 744
23. Maquoi E., Sounni N. E., Devy L., Olivier F., Frankenne F., Krell H.-W., Grams F., Foidart J.-M., Nol A., Anti-invasive, antitumoral, and antiangiogenic efficacy of a pyrimidine-2,4,6-trione derivative, an orally active and selective matrix metalloproteinases inhibitor Clinical Cancer Research 2004 10 12 4038 4047
24. Zucker S., Vacirca J., Role of matrix metalloproteinases (MMPs) in colorectal cancer Cancer and Metastasis Reviews 2004 23 1-2 101 117
25. Balbn M., Fueyo A., Tester A. M., Pends A. M., Pitiot A. S., Astudillo A., Overall C. M., Shapiro S. D., Lpez-Otn C., Loss of collagenase-2 confers increased skin tumor susceptibility to male mice Nature Genetics 2003 35 3 252 257
26. Gutirrez-Fernndez A., Inada M., Balbn M., Fueyo A., Pitiot A. S., Astudillo A., Hirose K., Hirata M., Shapiro S. D., Nol A., Werb Z., Krane S. M., Lpez-Otn C., Puente X. S., Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8) FASEB Journal 2007 21 10 2580 2591
27. Nixon A. E., Wood C. R., Engineered protein inhibitors of proteases Current Opinion in Drug Discovery and Development 2006 9 2 261 268
28. Hoet R. M., Cohen E. H., Kent R. B., Rookey K., Schoonbroodt S., Hogan S., Rem L., Frans N., Daukandt M., Pieters H., Van Hegelsom R., Coolen-Van Neer N., Nastri H. G., Rondon I. J., Leeds J. A., Hufton S. E., Huang L., Kashin I., Devlin M., Kuang G., Steukers M., Viswanathan M., Nixon A. E., Sexton D. J., Hoogenboom H. R., Ladner R. C., Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity Nature Biotechnology 2005 23 3 344 348
29. Devy L., Huang L., Naa L., Yanamandra N., Pieters H., Frans N., Chang E., Tao Q., Vanhove M., Lejeune A., Van Gool R., Sexton D. J., Kuang G., Rank D., Hogan S., Pazmany C., Ma Y. L., Schoonbroodt S., Nixon A. E., Ladner R. C., Hoet R., Henderikx P., Tenhoor C., Rabbani S. A., Valentino M. L., Wood C. R., Dransfield D. T., Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis Cancer Research 2009 69 4 1517 1526
30. Sato H., Kinoshita T., Takino T., Nakayama K., Seiki M., Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2 FEBS Letters 1996 393 1 101 104
31. Knuper V., Will H., Lpez-Otin C., Smith B., Atkinson S. J., Stanton H., Hembry R. M., Murphy G., Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme Journal of Biological Chemistry 1996 271 29 17124 17131
32. Udenfriend S., Kodukula K., How glycosylphosphatidylinositol-anchored membrane proteins are made Annual Review of Biochemistry 1995 64 563 591
33. English J. L., Kassiri Z., Koskivirta I., Atkinson S. J., Di Grappa M., Soloway P. D., Nagase H., Vuorio E., Murphy G., Khokha R., Individual Timp deficiencies differentially impact pro-MMP-2 activation Journal of Biological Chemistry 2006 281 15 10337 10346
34. Ohuchi E., Imai K., Fujii Y., Sato H., Seiki M., Okada Y., Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules Journal of Biological Chemistry 1997 272 4 2446 2451
35. D'Ortho M.-P., Will H., Atkinson S., Butler G., Messent A., Gavrilovic J., Smith B., Timpl R., Zardi L., Murphy G., Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases European Journal of Biochemistry 1997 250 3 751 757
36. Hotary K. B., Allen E. D., Brooks P. C., Datta N. S., Long M. W., Weiss S. J., Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix Cell 2003 114 1 33 45
37. Stetler-Stevenson W. G., Yu A. E., Proteases in invasion: matrix metalloproteinases Seminars in Cancer Biology 2001 11 2 143 152
38. Wolf K., Wu Y. I., Liu Y., Geiger J., Tam E., Overall C., Stack M. S., Friedl P., Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion Nature Cell Biology 2007 9 8 893 904
39. Strongin A. Y., Collier I., Bannikov G., Marmer B. L., Grant G. A., Goldberg G. I., Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease Journal of Biological Chemistry 1995 270 10 5331 5338
40. Hernandez-Barrantes S., Bernardo M., Toth M., Fridman R., Regulation of membrane type-matrix metalloproteinases Seminars in Cancer Biology 2002 12 2 131 138
41. McQuibban G. A., Gong J.-H., Wong J. P., Wallace J. L., Clark-Lewis I., Overall C. M., Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo Blood 2002 100 4 1160 1167
42. McQuibban G. A., Butler G. S., Gong J.-H., Bendall L., Power C., Clark-Lewis I., Overall C. M., Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1 Journal of Biological Chemistry 2001 276 47 43503 43508
43. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., Seiki M., Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration Journal of Cell Biology 2001 153 5 893 904
44. Belkin A. M., Akimov S. S., Zaritskaya L. S., Ratnikov B. I., Deryugina E. I., Strongin A. Y., Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion Journal of Biological Chemistry 2001 276 21 18415 18422
45. Rozanov D. V., Hahn-Dantona E., Strickland D. K., Strongin A. Y., The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells Journal of Biological Chemistry 2004 279 6 4260 4268
46. Zhang J., Sarkar S., Yong V. W., The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase Carcinogenesis 2005 26 12 2069 2077
47. Morrison C. J., Butler G. S., Bigg H. F., Roberts C. R., Soloway P. D., Overall C. M., Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway Journal of Biological Chemistry 2001 276 50 47402 47410
48. Matsumoto S.-I., Katoh M., Saito S., Watanabe T., Masuho Y., Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA Biochimica et Biophysica Acta 1997 1354 2 159 170
49. Shimada T., Nakamura H., Ohuchi E., Fuj Y. II, Murakami Y., Sato H., Seiki M., Okada Y., Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase European Journal of Biochemistry 1999 262 3 907 914 (Pubitemid 29291051)
50. Zhao H., Bernardo M. M., Osenkowski P., Sohail A., Pei D., Nagase H., Kashiwagi M., Soloway P. D., DeClerck Y. A., Fridman R., Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 regulates pro-MMP-2 activation Journal of Biological Chemistry 2004 279 10 8592 8601
51. Wang X., Yi J., Lei J., Pei D., Expression, purification and charaterization of recombinant mouse MT5-MMP protein products FEBS Letters 1999 462 3 261 266
52. Monea S., Jordan B. A., Srivastava S., DeSouza S., Ziff E. B., Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins Journal of Neuroscience 2006 26 8 2300 2312
53. Llano E., Pends A. M., Freije J. P., Nakano A., Knuper V., Murphy G., Lpez-Otin C., Identification and characterization of human MT5-MMP, a new membrane- bound activator of progelatinase a overexpressed in brain tumors Cancer Research 1999 59 11 2570 2576
54. Pei D., Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP Journal of Biological Chemistry 1999 274 13 8925 8932
55. Takino T., Koshikawa N., Miyamori H., Tanaka M., Sasaki T., Okada Y., Seiki M., Sato H., Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases Oncogene 2003 22 30 4617 4626
56. Kolkenbrock H., Essers L., Ulbrich N., Will H., Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase Biological Chemistry 1999 380 9 1103 1108
57. Sohail A., Sun Q., Zhao H., Bernardo M. M., Cho J.-A., Fridman R., MT4-(MMP17) and MT6-MMP (MMP25), a unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer Cancer and Metastasis Reviews 2008 27 2 289 302
58. English W. R., Puente X. S., Freije J. M. P., Knuper V., Amour A., Merryweather A., Lpez-Otn C., Murphy G., Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor- convertase activity but does not activate pro-MMP2 Journal of Biological Chemistry 2000 275 19 14046 14055
59. Kang T., Yi J., Guo A., Wang X., Overall C. M., Jiang W., Elde R., Borregaard N., Pei D., Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils Journal of Biological Chemistry 2001 276 24 21960 21968
60. English W. R., Velasco G., Stracke J. O., Knuper V., Murphy G., Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25) FEBS Letters 2001 491 1-2 137 142
61. Llano E., Pends A. M., Knuper V., Sorsa T., Salo T., Salido E., Murphy G., Simmer J. P., Bartlett J. D., Lpez-Otn C., Identification and structural and functional characterization of human enamelysin (MMP-20) Biochemistry 1997 36 49 15101 15108
62. Yoshiyama Y., Sato H., Seiki M., Shinagawa A., Takahashi M., Yamada T., Expression of the membrane-type 3 matrix metalloproteinase (MT3-MMP) in human brain tissues Acta Neuropathologica 1998 96 4 347 350 (Pubitemid 28451139)
63. Takino T., Sato H., Shinagawa A., Seiki M., Identification of the second membrane-type matrix metalloproteinase (MT- MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family Journal of Biological Chemistry 1995 270 39 23013 23020
64. Pei D., Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage Cell Research 1999 9 4 291 303
65. Will H., Hinzmann B., cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment European Journal of Biochemistry 1995 231 3 602 608
66. Puente X. S., Pends A. M., Llano E., Velasco G., Lpez-Otn C., Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma Cancer Research 1996 56 5 944 949
67. Maquoi E., Frankenne F., Nol A., Krell H.-W., Grams F., Foidart J.-M., Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells Experimental Cell Research 2000 261 2 348 359
68. Remacle A., Murphy G., Roghi C., Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface Journal of Cell Science 2003 116 19 3905 3916
69. Hotary K., Li X.-Y., Allen E., Stevens S. L., Weiss S. J., A cancer cell metalloprotease triad regulates the basement membrane transmigration program Genes and Development 2006 20 19 2673 2686
70. Hotary K. B., Yana I., Sabeh F., Li X.-Y., Holmbeck K., Birkedal-Hansen H., Allen E. D., Hiraoka N., Weiss S. J., Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes Journal of Experimental Medicine 2002 195 3 295 308
71. Mitra A., Chakrabarti J., Banerji A., Chatterjee A., Cell membrane-associated MT1-MMP dependent activation of MMP-2 in SiHa (human cervical cancer) cells Journal of Environmental Pathology, Toxicology and Oncology 2006 25 4 655 666
72. Knuper V., Bailey L., Worley J. R., Soloway P., Patterson M. L., Murphy G., Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13 FEBS Letters 2002 532 1-2 127 130
73. Takino T., Sato H., Shinagawa A., Seiki M., Identification of the second membrane-type matrix metalloproteinase (MT- MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family Journal of Biological Chemistry 1995 270 39 23013 23020
74. Sato H., Okada Y., Seiki M., Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion Thrombosis and Haemostasis 1997 78 1 497 500
75. Tanaka M., Sato H., Takino T., Iwata K., Inoue M., Seiki M., Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product FEBS Letters 1997 402 2-3 219 222
76. Bar-Or A., Nuttall R. K., Duddy M., Alter A., Kim H. J., Ifergan I., Pennington C. J., Bourgoin P., Edwards D. R., Yong V. W., Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis Brain 2003 126 12 2738 2749
77. Shofuda K.-I., Nagashima Y., Kawahara K., Yasumitsu H., Miki K., Miyazaki K., Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury Laboratory Investigation 1998 78 8 915 923
78. Lefleur M. A., Handsley M. M., Knuper V., Murphy G., Edwards D. R., Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs) Journal of Cell Science 2002 115 17 3427 3438
79. Thret N., Musso O., L'Helgoualc'h A., Campion J.-P., Clment B., Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPS)in association with MMP2 activation in injured human livers American Journal of Pathology 1998 153 3 945 954
80. Bjrn S. F., Hastrup N., Larsen J. F., Lund L. R., Pyke C., Messenger RNA for membrane-type 2 matrix metalloproteinase, MT2-MMP, is expressed in human placenta of first trimester Placenta 2000 21 2-3 170 176
81. Kim M. H., Albertsson P., Xue Y., Kitson R. P., Nannmark U., Goldfarb R. H., Expression of matrix metalloproteinases and their inhibitors by rat NK cells: inhibition of their expression by genistein In Vivo 2000 14 5 557 564 (Pubitemid 34097516)
82. Toft-Hansen H., Nuttall R. K., Edwards D. R., Owens T., Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis Journal of Immunology 2004 173 8 5209 5218
83. Plaisier M., Kapiteijn K., Koolwijk P., Fijten C., Hanemaaijer R., Grimbergen J. M., Mulder-Stapel A., Quax P. H. A., Helmerhorst F. M., Van Hinsbergh V. W. M., Involvement of membrane-type matrix metalloproteinases (MT-MMPs) in capillary tube formation by human endometrial microvascular endothelial cells: role of MT3-MMP Journal of Clinical Endocrinology and Metabolism 2004 89 11 5828 5836
84. Noirey N., Staquet M.-J., Gariazzo M.-J., Serres M., Andr C., Schmitt D., Vincent C., Relationship between expression of matrix metalloproteinases and migration of epidermal and in vitro generated Langerhans cells European Journal of Cell Biology 2002 81 7 383 389
85. Bernal F., Hartung H.-P., Kieseier B. C., Tissue mRNA expression in rat of newly described matrix metalloproteinases Biological Research 2005 38 2-3 267 271
86. Kajita M., Kinoh H., Ito N., Takamura A., Itoh Y., Okada A., Sato H., Seiki M., Human membrane type-4 matrix metalloproteinase (MT4-MMP) is encoded by a novel major transcript: isolation of complementary DNA clones for human and mouse mt4-mmp transcripts FEBS Letters 1999 457 3 353 356
87. Ota I., Li X.-Y., Hu Y., Weiss S. J., Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1 Proceedings of the National Academy of Sciences of the United States of America 2009 106 48 20318 20323
88. Li X.-Y., Ota I., Yana I., Sabeh F., Weiss S. J., Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase Molecular Biology of the Cell 2008 19 8 3221 3233
89. Holmbeck K., Bianco P., Caterina J., Yamada S., Kromer M., Kuznetsov S. A., Mankani M., Gehron Robey P., Poole A. R., Pidoux I., Ward J. M., Birkedal-Hansen H., MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover Cell 1999 99 1 81 92
90. Ogura S., Ohdaira T., Hozumi Y., Omoto Y., Nagai H., Metastasis-related factors expressed in pT1 pN0 breast cancer: assessment of recurrence risk Journal of Surgical Oncology 2007 96 1 46 53
91. Rozanov D. V., Savinov A. Y., Williams R., Liu K., Golubkov V. S., Krajewski S., Strongin A. Y., Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer Cancer Research 2008 68 11 4086 4096
92. Tsunezuka Y., Kinoh H., Takino T., Watanabe Y., Okada Y., Shinagawa A., Sato H., Seiki M., Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay Cancer Research 1996 56 24 5678 5683
93. Gilles C., Polette M., Piette J., Munaut C., Thompson E. W., Birembaut P., Foidart J.-M., High level of MT-MMP expression is associated with invasiveness of cervical cancer cells International Journal of Cancer 1996 65 2 209 213
94. Nomura H., Sato H., Seiki M., Mai M., Okada Y., Expression of membrane-type matrix metalloproteinase in human gastric carcinomas Cancer Research 1995 55 15 3263 3266
95. Okudera K., Kamata Y., Takanashi S., Hasegawa Y., Tsushima T., Ogura Y., Nakanishi K., Sato H., Okumura K., Small adenocarcinoma of the lung: prognostic significance of central fibrosis chiefly because of its association with angiogenesis and lymphangiogenesis Pathology International 2006 56 9 494 502
96. Atkinson J. M., Pennington C. J., Martin S. W., Anikin V. A., Mearns A. J., Loadman P. M., Edwards D. R., Gill J. H., Membrane type matrix metalloproteinases (MMPs) show differential expression in non-small cell lung cancer (NSCLC) compared to normal lung: correlation of MMP-14 mRNA expression and proteolytic activity European Journal of Cancer 2007 43 11 1764 1771
97. Janowska-Wieczorek A., Wysoczynski M., Kijowski J., Marquez-Curtis L., Machalinski B., Ratajczak J., Ratajczak M. Z., Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer International Journal of Cancer 2005 113 5 752 760
98. Gilles C., Polette M., Seiki M., Birembaut P., Thompson E. W., Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma Laboratory Investigation 1997 76 5 651 660 (Pubitemid 27225095)
99. Nabeshima K., Inoue T., Shimao Y., Okada Y., Itoh Y., Seiki M., Koono M., Front-cell-specific expression of membrane-type 1 matrix metalloproteinase and gelatinase A during cohort migration of colon carcinoma cells induced by hepatocyte growth factor/scatter factor Cancer Research 2000 60 13 3364 3369
100. Rosenthal E. L., Matrisian L. M., Matrix metalloproteases in head and neck cancer Head and Neck 2006 28 7 639 648
101. Yoshida S., Takahashi H., Expression of extracellular matrix molecules in brain metastasis Journal of Surgical Oncology 2009 100 1 65 68
102. Bartolom R. A., Ferreiro S., Miquilena-Colina M. E., Martnez-Prats L., Soto-Montenegro M. L., Garca-Bernal D., Vaquero J. J., Agami R., Delgado R., Desco M., Snchez-Mateos P., Teixid J., The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs American Journal of Pathology 2009 174 2 602 612
103. Cavalheiro B. G., Junqueira C. R., Brando L. G., Expression of membrane type 1 matrix metalloproteinase in medullary thyroid carcinoma: prognostic implications Head and Neck 2010 32 1 58 67
104. Starska K., Stasikowska O., ukomski M., Lewy-Trenda I., Correlation of membrane type I matrix metalloproteinase (MT1-MMP) expression with clinicomorphological features of tumor front in squamous cell carcinoma of the larynx Polski Merkuriusz Lekarski 2007 23 135 188 191
105. Zhang H., Liu M., Sun Y., Lu J., MMP-14 can serve as a prognostic marker in patients with supraglottic cancer European Archives of Oto-Rhino-Laryngology 2009 266 9 1427 1434
106. Bendardaf R., Lamlum H., Vihinen P., Ristamki R., Laine J., Pyrhnen S., Low collagenase-1 (MMP-1) and MT1-MMP expression levels are favourable survival markers in advanced colorectal carcinoma Oncology 2003 65 4 337 346
107. Jiang W. G., Davies G., Martin T. A., Parr C., Watkins G., Mason M. D., Mansel R. E., Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells International Journal of Molecular Medicine 2006 17 4 583 590
108. Ttu B., Brisson J., Wang C. S., Lapointe H., Beaudry G., Blanchette C., Trudel D., The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis Breast Cancer Research 2006 8 3, article R28
109. Mimori K., Ueo H., Shirasaka C., Mori M., Clinical significance of MT1-MMP mRNA expression in breast cancer Oncology Reports 2001 8 2 401 403
110. Kikuchi R., Noguchi T., Takeno S., Kubo N., Uchida Y., Immunohistochemical detection of membrane-type-1-matrix metalloproteinase in colorectal carcinoma British Journal of Cancer 2000 83 2 215 218
111. Ohnishi Y., Tajima S., Ishibashi A., Coordinate expression of membrane type-matrix metalloproteinases-2 and 3 (MT2-MMP and MT3-MMP) and matrix metalloproteinase-2 (MMP-2) in primary and metastatic melanoma cells European Journal of Dermatology 2001 11 5 420 423
112. Ueno H., Nakamura H., Inoue M., Imai K., Noguchi M., Sato H., Seiki M., Okada Y., Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas Cancer Research 1997 57 10 2055 2060
113. Ellenrieder V., Alber B., Lacher U., Hendler S. F., Menke A., Boeck W., Wagner M., Wilda M., Friess H., Bchler M., Adler G., Gress T. M., Role of MT-MMPs and MMP-2 in pancreatic cancer progression International Journal of Cancer 2000 85 1 14 20
114. Abraham R., Schfer J., Rothe M., Bange J., Knyazev P., Ullrich A., Identification of MMP-15 as an anti-apoptotic factor in cancer cells Journal of Biological Chemistry 2005 280 40 34123 34132
115. Iida J., Pei D., Kang T., Simpson M. A., Herlyn M., Furcht L. T., McCarthy J. B., Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen Journal of Biological Chemistry 2001 276 22 18786 18794
116. Luo Y. P., Zhong M., Wang L. P., Zhong M., Sun G. Q., Li J., Inhibitory effects of RNA interference on MMP-24 expression and invasiveness of ovarian cancer SKOV(3) cells Nan Fang Yi Ke Da Xue Xue Bao 2009 29 4 781 784
117. Chabottaux V., Sounni N. E., Pennington C. J., English W. R., Van Den Brle F., Blacher S., Gilles C., Munaut C., Maquoi E., Lopez-Otin C., Murphy G., Edwards D. R., Foidart J.-M., Nol A., Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases Cancer Research 2006 66 10 5165 5172
118. Chabottaux V., Ricaud S., Host L., Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture Journal of Cellular and Molecular Medicine 2009 13 4002 4013
119. Velasco G., Cal S., Merlos-Surez A., Ferrando A. A., Alvarez S., Nakano A., Arribas J., Lpez-Otn C., Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors Cancer Research 2000 60 4 877 882
120. Sun Q., Weber C. R., Sohail A., Bernardo M. M., Toth M., Zhao H., Turner J. R., Fridman R., MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties Journal of Biological Chemistry 2007 282 30 21998 22010
121. Wallard M. J., Pennington C. J., Veerakumarasivam A., Burtt G., Mills I. G., Warren A., Leung H. Y., Murphy G., Edwards D. R., Neal D. E., Kelly J. D., Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma British Journal of Cancer 2006 94 4 569 577
122. Riddick A. C. P., Shukla C. J., Pennington C. J., Bass R., Nuttall R. K., Hogan A., Sethia K. K., Ellis V., Collins A. T., Maitland N. J., Ball R. Y., Edwards D. R., Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues British Journal of Cancer 2005 92 12 2171 2180
123. Nuttall R. K., Pennington C. J., Taplin J., Wheal A., Yong V. W., Forsyth P. A., Edwards D. R., Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells Molecular Cancer Research 2003 1 5 333 345
124. Hegeds L., Cho H., Xie X., Eliceiri G. L., Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness Journal of Cellular Physiology 2008 216 2 480 485
125. Cauwe B., Van den Steen P. E., Opdenakker G., The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases Critical Reviews in Biochemistry and Molecular Biology 2007 42 3 113 185
126. Miller M.-C., Manning H. B., Jain A., Troeberg L., Dudhia J., Essex D., Sandison A., Seiki M., Nanchahal J., Nagase H., Itoh Y., Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis Arthritis and Rheumatism 2009 60 3 686 697
127. Jain A., Miller M.-C., Troeberg L., Itoh Y., Brennan F., Nanchahal J., Invasive potential of human rheumatoid tenosynovial cells is in part MT1-MMP dependent Journal of Hand Surgery 2009 34 7 1282 1290
128. Konttinen Y. T., Ainola M., Valleala H., Ma J., Ida H., Mandelin J., Kinne R. W., Santavirta S., Sorsa T., Lpez-Otn C., Takagi M., Jumppanen M., Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis Annals of the Rheumatic Diseases 1999 58 11 691 697
129. Johnson J. L., Sala-Newby G. B., Ismail Y., Aguilera C. M., Newby A. C., Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 9 1647 1653
130. Johnson J. L., Fritsche-Danielson R., Behrendt M., Westin-Eriksson A., Wennbo H., Herslof M., Elebring M., George S. J., McPheat W. L., Jackson C. L., Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability Cardiovascular Research 2006 71 3 586 595
131. Johnson J. L., George S. J., Newby A. C., Jackson C. L., Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries Proceedings of the National Academy of Sciences of the United States of America 2005 102 43 15575 15580
132. Romanic A. M., Burns-Kurtis C. L., Ao Z., Arleth A. J., Ohlstein E. H., Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients American Journal of Physiology 2001 281 2 F309 F317
133. Komori K., Nonaka T., Okada A., Kinoh H., Hayashita-Kinoh H., Yoshida N., Yana I., Seiki M., Absence of mechanical allodynia and A -fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase FEBS Letters 2004 557 13 125 128
134. Gao G., Plaas A., Thompson V. P., Jin S., Zuo F., Sandy J. D., ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1 Journal of Biological Chemistry 2004 279 11 10042 10051
135. Patwari P., Gao G., Lee J. H., Grodzinsky A. J., Sandy J. D., Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage Osteoarthritis and Cartilage 2005 13 4 269 277
136. Rikimaru A., Komori K., Sakamoto T., Ichise H., Yoshida N., Yana I., Seiki M., Establishment of an MT4-MMP-deficient mouse strain representing an efficient tracking system for MT4-MMP/MMP-17 expression in vivo using -galactosidase Genes to Cells 2007 12 9 1091 1100
137. Shiryaev S. A., Savinov A. Y., Cieplak P., Boris I., Ratnikov B. I., Motamedchaboki K., Smith J. W., Strongin A. Y., Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis PLoS ONE 2009 4 3, article e4952
138. Clancy B. M., Johnson J. D., Lambert A.-J., Rezvankhah S., Wong A., Resmini C., Feldman J. L., Leppanen S., Pittman D. D., A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps Bone 2003 33 1 46 63
139. Riley G., Tendinopathyfrom basic science to treatment Nature Clinical Practice Rheumatology 2008 4 2 82 89